Methods and systems for diagnosing from whole genome sequencing data
A processor-based method using Gaussian mixture models for analyzing whole genome sequencing data addresses the challenge of genotyping SMN1/SMN2 and CYP2D6/CYP2D7 genes, enabling precise copy number determination and improved diagnostic and treatment strategies.
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- ILLUMINA INC
- Filing Date
- 2020-08-26
- Publication Date
- 2026-07-16
AI Technical Summary
Genotyping of SMN1 and CYP2D6 genes is challenging due to their high sequence similarity with their paralogs SMN2 and CYP2D7, respectively, leading to difficulties in accurately determining copy numbers and genotyping.
A processor-implemented method using Gaussian mixture models to analyze whole genome sequencing data, aligning sequence reads to specific gene regions, and determining normalized numbers to accurately calculate copy numbers of SMN1/SMN2 and CYP2D6/CYP2D7 genes, followed by identifying the most likely combination of copy numbers based on alignment support and posterior probabilities.
Enables precise determination of SMN1 and CYP2D6 gene copy numbers and genotyping, facilitating accurate diagnosis and treatment recommendations for spinal muscular atrophy and drug metabolism, respectively.
Smart Images

Figure 00000001_0000 
Figure 00000119_0000 
Figure 00000119_0001